Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Solid Tumors
Clinical trial NCT05359354 · UNKNOWN
Trial details
- NCT number
- NCT05359354
- Sponsor
- YueJuan Cheng
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2025-09-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.